Moriya T, Yamanouchi S, Fukushima T, Shimazoe T, Shibata S, Watanabe S
Department of Pharmacology, Faculty of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.
Brain Res. 1996 Nov 18;740(1-2):261-7. doi: 10.1016/s0006-8993(96)00860-8.
We examined the role of serotonin 1A (5-HT1A) receptors in the inhibitory effects of methamphetamine (MA) on photic entrainment to the circadian pacemaker in the suprachiasmatic nucleus (SCN) of rodents. MA inhibited optic nerve stimulation-evoked field potential in the SCN, light-induced Fos expression in the SCN and light-induced phase shift of hamster wheel-running rhythm. NAN-190, a 5-HT1A receptor antagonist, eliminated the inhibitory effects of MA. NAN-190 has also been reported to antagonize alpha 1 adrenergic receptors. However, prazosin, which selectively antagonizes alpha 1 adrenergic receptors, did not affect the inhibitory action of MA on light-induced Fos expression. In addition, parachloroamphetamine, which is known to be a 5-HT releaser, dose-dependently inhibited light-induced phase shift of wheel-running rhythm. These findings suggest that elevation of endogenous 5-HT levels by MA inhibits the photic entraining responses of the circadian pacemaker in the SCN via 5-HT1A receptor stimulation of the 5-HT released by MA.
我们研究了5-羟色胺1A(5-HT1A)受体在甲基苯丙胺(MA)对啮齿动物视交叉上核(SCN)中昼夜节律起搏器的光诱导同步化抑制作用中的角色。MA抑制了SCN中视神经刺激诱发的场电位、SCN中光诱导的Fos表达以及仓鼠轮跑节律的光诱导相移。5-HT1A受体拮抗剂NAN-190消除了MA的抑制作用。据报道,NAN-190也能拮抗α1肾上腺素能受体。然而,选择性拮抗α1肾上腺素能受体的哌唑嗪并不影响MA对光诱导Fos表达的抑制作用。此外,已知为5-羟色胺释放剂的对氯苯丙胺能剂量依赖性地抑制轮跑节律的光诱导相移。这些发现表明,MA使内源性5-羟色胺水平升高,通过刺激MA释放的5-羟色胺的5-HT1A受体,抑制了SCN中昼夜节律起搏器的光诱导同步化反应。